Treatment of Hypomagnesemia in Newborns
Magnesium sulfate is the recommended treatment for neonatal hypomagnesemia, administered parenterally at 0.1-0.2 mmol/kg/day (2.5-5.0 mg/kg/day) for preterm infants in the first days of life, with dosing adjusted based on serial blood magnesium measurements. 1
Diagnostic Approach
Before initiating treatment, recognize that:
- Normal magnesium range in newborns is 0.7-1.5 mmol/L (higher than adult values), so avoid using adult reference ranges which will lead to overdiagnosis 1
- 59% of neonates with total magnesium ≤0.65 mmol/L actually have normal ionized magnesium 2
- Ionized magnesium (normal 0.40-0.56 mmol/L) is the better indicator of true deficiency than total magnesium 1
- Red blood cell magnesium concentration (~2.5 mmol/L) represents the best tissue indicator 1
Check for concurrent hypocalcemia and hypomagnesemia together, as magnesium deficiency causes both deficient PTH release and peripheral PTH resistance, leading to hypocalcemia that won't respond to calcium alone 1, 3
Treatment Protocol
Parenteral Administration (Preferred Route)
Use magnesium sulfate, not magnesium chloride, as chloride increases anion gap and metabolic acidosis risk 1
Dosing by age/status:
- Preterm infants (first days of life): 0.1-0.2 mmol/kg/day (2.5-5.0 mg/kg/day) 1
- Growing premature infants: 0.2-0.3 mmol/kg/day (5.0-7.5 mg/kg/day) 1
- Term newborns (0-6 months): 0.1-0.2 mmol/kg/day (2.4-5.0 mg/kg/day) 1
For symptomatic hypomagnesemia (seizures, tetany): A single dose of 6 mg elemental magnesium/kg given intravenously over 1 hour is safe and effective 2, 4. This dose does not cause dangerous hypermagnesemia (maximum observed 0.61 mmol/L) 2.
Oral Administration
For asymptomatic cases or maintenance after initial correction:
- Magnesium sulfate 50% USP: 0.1 ml/kg/day (approximately 0.2 mmol/kg/day) for 5 days 5
- Magnesium chloride 10%: 1.0 ml/kg/day (0.5 mmol/kg/day) for extended periods 5
Critical Special Circumstances
Maternal Magnesium Sulfate Exposure
If the mother received magnesium sulfate (for preeclampsia/tocolysis), LIMIT magnesium intake initially and adapt based on postnatal blood concentrations 1. These infants:
- May have high magnesium levels in first days of life
- Have low glomerular filtration rates limiting magnesium excretion
- Risk hypermagnesemia if given standard supplementation 1
Symptomatic Hypocalcemia with Hypomagnesemia
Magnesium sulfate is superior to calcium gluconate for neonatal tetany, even without documented hypomagnesemia 4. In a randomized trial, magnesium-treated infants had:
- Higher plasma calcium at 48 hours
- Fewer convulsions during and after treatment
- Better overall outcomes 4
The mechanism: Magnesium deficiency causes hypocalcemia through impaired PTH function; treating magnesium corrects the calcium without direct calcium supplementation 1, 3
Monitoring Requirements
Serial measurements are mandatory:
- Monitor serum magnesium, calcium, and phosphorus concentrations regularly 1
- Check ionized calcium alongside magnesium, as they are inversely correlated during treatment 2
- In infants with low baseline ionized magnesium, expect ionized calcium to increase with magnesium treatment 2
- Monitor for urine magnesium excretion as indicator of adequacy (similar to calcium/phosphorus monitoring) 1
Common Pitfalls to Avoid
Don't use calcium gluconate in glass vials - contaminated with aluminum; use polyethylene-packaged preparations 1
Don't treat based on total magnesium alone - measure ionized magnesium to prevent overtreatment 1, 2
Don't give standard magnesium doses to infants of magnesium-treated mothers - risk of hypermagnesemia 1
Don't treat hypocalcemia without checking magnesium - calcium supplementation alone will fail if hypomagnesemia is the underlying cause 1, 3, 4
Don't use magnesium chloride as first-line parenteral therapy - increases metabolic acidosis risk 1
Expected Outcomes
With appropriate magnesium supplementation: